TW202245790A - Ｇａｂａ－ａ正向異位調節劑的半檸檬酸鹽及其結晶型 - Google Patents

Ｇａｂａ－ａ正向異位調節劑的半檸檬酸鹽及其結晶型 Download PDF

Info

Publication number
TW202245790A
TW202245790A TW111105875A TW111105875A TW202245790A TW 202245790 A TW202245790 A TW 202245790A TW 111105875 A TW111105875 A TW 111105875A TW 111105875 A TW111105875 A TW 111105875A TW 202245790 A TW202245790 A TW 202245790A
Authority
TW
Taiwan
Prior art keywords
compound
hemi
weight
citrate
salt
Prior art date
Application number
TW111105875A
Other languages
English (en)
Chinese (zh)
Inventor
多里斯 奈維爾
阿瑪德 哈夏許
卡爾 漢森
約翰 陳
Original Assignee
美商普雷西斯精密藥品股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商普雷西斯精密藥品股份有限公司 filed Critical 美商普雷西斯精密藥品股份有限公司
Publication of TW202245790A publication Critical patent/TW202245790A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
TW111105875A 2021-02-18 2022-02-17 Ｇａｂａ－ａ正向異位調節劑的半檸檬酸鹽及其結晶型 TW202245790A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163150782P 2021-02-18 2021-02-18
US63/150,782 2021-02-18

Publications (1)

Publication Number Publication Date
TW202245790A true TW202245790A (zh) 2022-12-01

Family

ID=82931143

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111105875A TW202245790A (zh) 2021-02-18 2022-02-17 Ｇａｂａ－ａ正向異位調節劑的半檸檬酸鹽及其結晶型

Country Status (5)

Country Link
US (2) US20240190910A1 (https=)
EP (1) EP4294819A4 (https=)
JP (1) JP2024506942A (https=)
TW (1) TW202245790A (https=)
WO (1) WO2022178000A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10562930B1 (en) 2018-08-31 2020-02-18 Praxis Precision Medicines, Inc. Salts and crystal forms of GABAA positive allosteric modulator
EP4514357A4 (en) * 2022-04-26 2026-04-29 Praxis Prec Medicines Inc METHODS OF TREATING NEUROLOGICAL DISORDERS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004072079A1 (en) * 2003-02-11 2004-08-26 Pfizer Limited Hydrated and anhydrous sildenafil hemi-citrate compound
US20060074059A1 (en) * 2004-08-26 2006-04-06 Goliber Philip A Isomorphic crystalline habits of 3alpha-hydroxy-21-(1'-imidazolyl)-3beta-methoxymethyl-5alpha-pregnane-20-one
ATE538797T1 (de) * 2005-06-09 2012-01-15 Euro Celtique Sa Pharmazeutische zusammensetzungen mit neuroaktivem steroid und verwendungen davon
US10562930B1 (en) * 2018-08-31 2020-02-18 Praxis Precision Medicines, Inc. Salts and crystal forms of GABAA positive allosteric modulator

Also Published As

Publication number Publication date
US20240190910A1 (en) 2024-06-13
WO2022178000A1 (en) 2022-08-25
US20220289789A1 (en) 2022-09-15
JP2024506942A (ja) 2024-02-15
US11697669B2 (en) 2023-07-11
EP4294819A1 (en) 2023-12-27
EP4294819A4 (en) 2024-12-18

Similar Documents

Publication Publication Date Title
US12595254B2 (en) Crystal form of Resmetirom, preparation method therefor, and use thereof
EP3177629B1 (en) Novel hydrates of dolutegravir sodium
US10759779B2 (en) Crystalline form of orexin receptor antagonist, processes for preparation thereof and use thereof
TW202245790A (zh) Ｇａｂａ－ａ正向異位調節劑的半檸檬酸鹽及其結晶型
US11339158B2 (en) Crystalline form of valbenazine ditosylate, processes for preparation thereof and use thereof
US20250042866A1 (en) Crystal form of blarcamesine hydrochloride, method for preparing same, and use therof
KR101851118B1 (ko) 랄핀아미드 메탄설포네이트 염들 또는 이들의 ｒ―에난티오머들의 제조 방법
WO2017109772A1 (en) Amorphous form of selexipag
CN111527089B (zh) Acalabrutinib的新晶型及其制备方法和用途
JP2026508907A (ja) ニロガセスタット二臭化水素酸塩の結晶形、及びその調製方法並びに用途
CN120826397A (zh) 嘧啶三唑化合物的固体及共晶体形式
US20050090537A1 (en) Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
WO2019105359A1 (zh) Acalabrutinib的晶型及其制备方法和用途
JP2012180280A (ja) 貯蔵安定性が改善された固形製剤
US10961235B2 (en) Crystalline form of masitinib
CN111417624B (zh) Eb-1020的晶型及其制备方法和用途
CN116171277B (zh) Pn6047盐酸盐的多晶型物
US20220267326A1 (en) Crystalline form of valbenazine ditosylate, processes for preparation thereof and use thereof
AU2021237686B2 (en) Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane carboxylic acid
CN121293190A (zh) 替戈拉生化合物的晶型及其制备方法和用途
US7595335B2 (en) Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
EA043692B1 (ru) Аморфный летермовир и содержащие его твердые фармацевтические препараты, предназначенные для перорального введения
HK1178519B (en) Metaxalone cocrystals